01 1Akorn Pharmaceuticals
02 1Amphastar Pharmaceuticals
03 2Bausch & Lomb Incorporated
04 1Halozyme Therapeutics
05 1Xixia Pharmaceuticals (Pty) Ltd
01 1INJ
02 5INJECTABLE;INJECTION
01 1Originator
02 5Blank
01 1AMPHADASE
02 1HYDASE
03 1HYLENEX RECOMBINANT
04 1Hyalase
05 2VITRASE
01 1South Africa
02 5USA
Regulatory Info :
Registration Country : USA
Brand Name : HYDASE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 150 UNITS/ML
Packaging :
Approval Date :
Application Number : 21716
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : AMPHADASE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 150 UNITS/ML
Packaging :
Approval Date :
Application Number : 21665
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : VITRASE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 6,200 UNITS/VIAL
Packaging :
Approval Date :
Application Number : 21640
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : VITRASE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 200 UNITS/VIAL
Packaging :
Approval Date :
Application Number : 21640
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
HYALURONIDASE RECOMBINANT HUMAN
Brand Name : HYLENEX RECOMBINANT
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 150 UNITS/ML
Packaging :
Approval Date :
Application Number : 21859
Regulatory Info :
Registration Country : USA
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Hyalase
Dosage Form : INJ
Dosage Strength : 1500u.i.
Packaging : 1X10u.i.
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?